Lyra Therapeutics, Inc. LYRA
0.19 USD 0.00 (+0.00%)
At closeNov 6, 2026, 4:00 PM EST
0.35 +0.16 +84.47%
After hours · Nov 6, 4:00 PM ET
0.3623 Day range 0.52
0.0004 52-week range 4.90
- YTD
- -93.83%
- 1 year
- -96.12%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 1.53M | 1.56M | 1.36M | 285.00K | 0 | |
| 1.53M | 1.56M | 1.36M | 285.00K | 0 | |
| -96.35M | -67.12M | -56.31M | -43.62M | -22.21M | |
| -93.44M | -62.68M | -55.28M | -43.51M | -22.13M | |
| -72.00 | -63.00 | -92.00 | -168.00 | -130.00 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 42.57M | 23.75M | 33.94M | 46.08M | 74.92M | |
| 66.35M | 142.60M | 109.97M | 54.87M | 80.83M | |
| 54.75M | 53.18M | 29.21M | 20.55M | 6.34M | |
| 34.38M | 26.88M | 2.22M | 1.45M | 2.44M | |
| 11.59M | 89.42M | 80.75M | 34.32M | 74.49M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -70.01M | -63.30M | -43.38M | -25.82M | -21.14M | |
| 80.31M | -12.58M | -65.01M | -3.38M | -1.77M | |
| 8.53M | 65.69M | 96.26M | 359.00K | 87.70M | |
| -2.34M | -1.05M | -164.00K | -3.38M | -1.77M | |
| 18.82M | -10.20M | -12.13M | -28.85M | 64.78M |